Bavarian Nordic (OTCMKTS:BVNRY) Stock Crosses Above 50-Day Moving Average – Here’s Why

Bavarian Nordic (OTCMKTS:BVNRY) shares crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $10.01 and traded as high as $10.23. Bavarian Nordic shares last traded at $10.23, with a volume of 327 shares.

Bavarian Nordic Price Performance

The company’s 50 day simple moving average is $10.01 and its 200 day simple moving average is $11.11. The firm has a market cap of $2.43 billion, a price-to-earnings ratio of 6.60 and a beta of 1.36.

Bavarian Nordic (OTCMKTS:BVNRY) last released its earnings results on Friday, November 14th. The company reported $0.72 earnings per share (EPS) for the quarter. Bavarian Nordic had a return on equity of 20.47% and a net margin of 35.96%.The firm had revenue of $281.11 million during the quarter. As a group, analysts forecast that Bavarian Nordic will post 0.67 earnings per share for the current year.

About Bavarian Nordic

Bavarian Nordic is a fully integrated biotechnology company specializing in the development, manufacture and commercialization of vaccines and immunotherapies. Founded in 1994 and headquartered in Martinsried, Germany, the company combines internal research capabilities with in-house manufacturing to address serious infectious diseases and cancer indications. Bavarian Nordic’s operations encompass preclinical research, clinical development and commercial supply, with a strategic focus on leveraging its proprietary viral vector platforms.

The company’s commercial portfolio includes approved prophylactic vaccines such as Jynneos™ (marketed as Imvamune®/Imvanex®) for the prevention of smallpox and monkeypox in the United States, European Union and Canada; Rabipur® for rabies prevention; and Encepur® against tick-borne encephalitis.